Related Experiment Video
Updated: Aug 8, 2026

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
Published on: October 30, 2016
Suppression of single and double nonsense mutations introduced into the diphtheria toxin A-chain gene: a potential
1Program in Molecular Biology, University of Colorado Cancer Center, Denver, USA.
Abstract:
We have previously shown that ablation of specific cells can be achieved through the transcriptionally regulated expression of the diphtheria toxin A-chain (DT-A) gene in both cell culture and transgenic mice. Such targeted toxin gene expression provides a novel approach to cancer and acquired immunodeficiency syndrome (AIDS) therapy. The use of mutants of DT-A with attenuated toxicity may allow targeting of cells for which only moderately selective gene regulatory elements are available. Alternatively, conditional mutants might be used to target cells in which conditions can be established for suppression of the mutation. We have investigated the effects of mutating selected serine codons to amber (TAG) nonsense codons in the DT-A coding sequence. In transient transfection of HeLa cells, DT-A activity was markedly reduced by the introduction of a single amber codon and was virtually eliminated by two amber mutations. Cotransfection of a serine inserting suppressor tRNA expression plasmid substantially restored DT-A expression from both single and double amber mutants. Expression of the same suppressor tRNA also suppressed a previously described amber mutation at the tyrosine codon 28 in DT-A. Thus, nonsense suppression can be used to control the expression of DT-A in mammalian cells, potentially allowing binary control over the targeting of tissues for selective ablation.
Insights
Researchers explored controlling diphtheria toxin A-chain (DT-A) gene expression using genetic mutations. They found that introducing specific mutations and suppressor tRNAs allows precise control over DT-A activity for targeted cell ablation.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Targeted gene therapy offers potential for treating diseases like cancer and AIDS.
- Diphtheria toxin A-chain (DT-A) gene expression can induce specific cell ablation.
- Modulating DT-A toxicity is crucial for targeting cells with limited regulatory elements.
Purpose of the Study:
- To investigate the use of nonsense suppression to control DT-A gene expression.
- To assess the impact of amber mutations on DT-A activity.
- To evaluate the potential for binary control over targeted tissue ablation.
Main Methods:
- Introducing amber (TAG) nonsense codons into the DT-A coding sequence.
- Transfecting HeLa cells with mutated DT-A constructs.
- Utilizing serine-inserting suppressor tRNA to restore DT-A expression.
Main Results:
- A single amber mutation significantly reduced DT-A activity.
- Two amber mutations virtually eliminated DT-A activity.
- Suppressor tRNA restored DT-A expression in mutated constructs, demonstrating control.
Conclusions:
- Nonsense suppression provides a mechanism to regulate DT-A expression in mammalian cells.
- This method enables conditional control over targeted cell ablation.
- Potential applications include precise cancer and AIDS therapy.
Related Concept Videos
In-vitro Mutagenesis
Gene Therapy
Diphtheria

